Bio-Gene Technology Ltd. (AU:BGT)
ASX:BGT
Australian Market
Holding AU:BGT?
Track your performance easily

Bio-Gene Technology Ltd. (BGT) Income Statement

4 Followers

Bio-Gene Technology Ltd. Income Statement

Last quarter (Q4 2022), Bio-Gene Technology Ltd.'s total revenue was AU$―, a decrease of ― from previous quarter. In Q4, Bio-Gene Technology Ltd.'s net income was AU$―. See Bio-Gene Technology Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20Jun 19
Total Revenue
-AU$ 879.78KAU$ 573.12KAU$ 907.58KAU$ 508.76K
Cost of Revenue
-----
Gross Profit
-AU$ 879.78KAU$ 573.12KAU$ 907.58KAU$ 508.76K
Operating Expense
-AU$ 3.85MAU$ 3.04MAU$ 3.07MAU$ 2.70M
Operating Income
-AU$ -2.97MAU$ -2.47MAU$ -2.16MAU$ -2.19M
Net Non Operating Interest Income Expense
-AU$ 52.86KAU$ 37.78KAU$ 63.25KAU$ 135.85K
Other Income Expense
-AU$ 6.48KAU$ 30.97KAU$ 164.55KAU$ 2.90K
Pretax Income
-AU$ -2.91MAU$ -2.40MAU$ -1.93MAU$ -2.06M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
-AU$ -2.91MAU$ -2.40MAU$ -1.93MAU$ -2.06M
Basic EPS
-AU$ -0.02AU$ -0.02AU$ -0.02AU$ -0.02
Diluted EPS
-AU$ -0.02AU$ -0.02AU$ -0.02AU$ -0.02
Basic Average Shares
-AU$ 153.34MAU$ 137.23MAU$ 119.37MAU$ 117.75M
Diluted Average Shares
-AU$ 153.34MAU$ 137.23MAU$ 119.37MAU$ 117.75M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
-----
Net Income From Continuing And Discontinued Operation
-AU$ -2.91MAU$ -2.40MAU$ -1.93MAU$ -2.06M
Normalized Income
-AU$ -2.91MAU$ -2.40MAU$ -1.93MAU$ -2.06M
Interest Expense
-----
EBIT
-AU$ -2.97MAU$ -2.47MAU$ -2.16MAU$ -2.19M
EBITDA
-AU$ -2.93MAU$ -2.41MAU$ -2.10MAU$ -2.15M
Currency in AUD

Bio-Gene Technology Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis